Display options
Share it on

Korean J Urol. 2010 Aug;51(8):511-7. doi: 10.4111/kju.2010.51.8.511. Epub 2010 Aug 18.

Bone morphogenetic protein signaling: implications in urology.

Korean journal of urology

Jeongyun Jeong, Dong Il Kang, Geun Taek Lee, Isaac Yi Kim

Affiliations

  1. Department of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

PMID: 20733955 PMCID: PMC2924553 DOI: 10.4111/kju.2010.51.8.511

Abstract

The bone morphogenetic proteins (BMPs), as members of the transforming growth factor-beta (TGF-beta) superfamily, not only control bone formation, but also regulate multiple key steps during embryonic development and differentiation. Furthermore, BMPs play critical roles in maintaining the homeostasis of the cardiovascular, pulmonary, reproductive, urogenital, and nervous systems in adult life. Like all members of the TGF-beta superfamily, BMP signaling is mediated through a heteromeric complex of type I and type II transmembrane serine/threonine kinase receptors. The subsequent signal transduction cascade includes either the canonical Smad-dependent or non-canonical Smad-independent pathways. Reflecting the critical function of BMPs, BMP signaling is tightly regulated at multiple steps by various mechanisms including extracellular endogenous antagonists, neutralizing antibodies/extracellular soluble receptor domains, small molecule inhibitors, cytoplasmic inhibitory Smads, and transcriptional co-repressors. Recently, dorsomorphin, the first small molecule inhibitor of BMP signaling, was identified and suggested as a useful tool for dissecting the mechanisms of signaling pathways and for developing novel therapeutics for diverse human diseases that are related to the BMP signaling pathways. In this article, we discuss various mechanisms involved in regulating BMP signaling pathways and their implications for urology.

Keywords: Bone morphogenetic proteins; Dorsomorphin; Signal transduction; Transforming growth factors

References

  1. Dev Biol. 2002 Oct 15;250(2):231-50 - PubMed
  2. Prostate. 2004 Apr 1;59(1):101-6 - PubMed
  3. Dev Biol. 2001 Dec 15;240(2):457-73 - PubMed
  4. J Cell Physiol. 2001 Jun;187(3):265-76 - PubMed
  5. Nature. 1999 Aug 12;400(6745):687-93 - PubMed
  6. Br J Cancer. 2005 Oct 17;93(8):949-52 - PubMed
  7. Science. 2004 Mar 12;303(5664):1684-6 - PubMed
  8. Cancer Res. 1997 Oct 1;57(19):4427-31 - PubMed
  9. Neoplasia. 2005 May;7(5):509-21 - PubMed
  10. Science. 1988 Dec 16;242(4885):1528-34 - PubMed
  11. Carcinogenesis. 2007 Jun;28(6):1153-62 - PubMed
  12. Nat Genet. 2003 Jul;34(3):303-7 - PubMed
  13. Cell. 1996 Aug 23;86(4):599-606 - PubMed
  14. J Bone Miner Res. 2002 Feb;17(2):293-300 - PubMed
  15. Nat Chem Biol. 2008 Jan;4(1):33-41 - PubMed
  16. Genes Dev. 1998 Jan 15;12(2):186-97 - PubMed
  17. J Biol Chem. 1997 Apr 25;272(17):11535-40 - PubMed
  18. J Cell Sci. 2000 Apr;113 ( Pt 7):1101-9 - PubMed
  19. J Urol. 2008 Dec;180(6):2660-7 - PubMed
  20. Growth Factors. 2004 Dec;22(4):233-41 - PubMed
  21. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7632-6 - PubMed
  22. Dev Biol. 1998 May 15;197(2):205-17 - PubMed
  23. Cancer Metastasis Rev. 2005 Jun;24(2):251-63 - PubMed
  24. Nat Rev Cancer. 2008 Oct;8(10):806-12 - PubMed
  25. Nature. 2008 Aug 21;454(7207):1000-4 - PubMed
  26. Int J Dev Biol. 1999;43(5):405-11 - PubMed
  27. Mol Cell. 1998 Apr;1(5):673-83 - PubMed
  28. Science. 1994 Apr 1;264(5155):101-4 - PubMed
  29. Development. 2000 Feb;127(4):821-30 - PubMed
  30. Dev Dyn. 1997 Mar;208(3):349-62 - PubMed
  31. Mol Biol Cell. 2008 Feb;19(2):457-64 - PubMed
  32. Cell Signal. 2004 Mar;16(3):291-9 - PubMed
  33. Mod Pathol. 2008 Dec;21(12):1436-43 - PubMed
  34. Kidney Blood Press Res. 2009;32(6):445-50 - PubMed
  35. Br J Cancer. 1992 Dec;66(6):1159-63 - PubMed
  36. Cancer Res. 2004 Nov 15;64(22):8276-84 - PubMed
  37. Cell. 2007 Oct 19;131(2):242-56 - PubMed
  38. Am J Pathol. 2007 Sep;171(3):1047-57 - PubMed
  39. Front Biosci. 2008 May 01;13:4726-39 - PubMed
  40. J Bone Miner Res. 2008 Mar;23(3):305-13 - PubMed
  41. Cell. 1999 Sep 3;98(5):573-83 - PubMed
  42. Bone. 2006 Jul;39(1):61-71 - PubMed
  43. Cancer Res. 2004 Oct 15;64(20):7355-60 - PubMed
  44. Development. 2004 Jul;131(14):3401-10 - PubMed
  45. Endocr Rev. 2003 Apr;24(2):218-35 - PubMed
  46. Mol Endocrinol. 2008 Dec;22(12):2689-702 - PubMed
  47. J Mol Histol. 2009 Oct;40(5-6):331-41 - PubMed
  48. FASEB J. 2007 Jan;21(1):256-64 - PubMed
  49. J Bone Joint Surg Am. 2003;85-A Suppl 3:44-51 - PubMed
  50. J Biol Chem. 2005 Jul 1;280(26):24443-50 - PubMed
  51. Nature. 1999 Feb 25;397(6721):707-10 - PubMed
  52. Biochem Biophys Res Commun. 1999 Jun 24;260(1):240-4 - PubMed
  53. J Biol Chem. 2002 Feb 15;277(7):5330-8 - PubMed
  54. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11740-4 - PubMed
  55. Mol Pharmacol. 2002 Jul;62(1):65-74 - PubMed
  56. Cell. 1998 Dec 11;95(6):737-40 - PubMed
  57. J Cell Biol. 2001 Dec 10;155(6):1017-27 - PubMed
  58. FEBS Lett. 2003 Jul 3;546(1):133-9 - PubMed
  59. Annu Rev Biochem. 1998;67:753-91 - PubMed
  60. Prostate. 2003 Mar 1;54(4):268-74 - PubMed
  61. Osteoarthritis Cartilage. 2009 Feb;17(2):263-70 - PubMed
  62. PLoS One. 2008 Aug 06;3(8):e2904 - PubMed
  63. J Cell Biol. 1995 Jul;130(1):217-26 - PubMed
  64. Biol Chem. 2004 Aug;385(8):697-710 - PubMed
  65. Int J Dev Biol. 2000 Apr;44(3):253-65 - PubMed
  66. Genesis. 2003 Jan;35(1):43-56 - PubMed
  67. Cancer Res. 2000 Jun 1;60(11):2840-4 - PubMed
  68. Genes Dev. 1995 Nov 15;9(22):2795-807 - PubMed
  69. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6046-51 - PubMed

Publication Types